{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:00:00Z","timestamp":1780606800292,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633,"],"award-info":[{"award-number":["UM1AI068633,"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10461-022-03841-z","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T13:02:41Z","timestamp":1662469361000},"page":"1030-1043","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9074-6751","authenticated-orcid":false,"given":"Brenda Gati","family":"Mirembe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Valdez","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"van der Straten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Nakalega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Cobbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyaradzo M.","family":"Mgodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley J.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufia","family":"Dadabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila E.","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonasagrie","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lameck","family":"Chinula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyne A.","family":"Akello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemensia","family":"Nakabiito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia E.","family":"Soto-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M.","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"3841_CR1","unstructured":"UNAIDS. Women and HIV. A spotlight on adolescent girls and young women. 2019."},{"key":"3841_CR2","doi-asserted-by":"crossref","unstructured":"Sahay S, et al., Understanding Issues Around Use of Oral Pre-Exposure Prophylaxis Among Female Sex Workers in India. 2021.","DOI":"10.21203\/rs.3.rs-493162\/v1"},{"issue":"1","key":"3841_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12978-019-0839-x","volume":"16","author":"K Gambir","year":"2019","unstructured":"Gambir K, et al. Opportunities and challenges for the introduction of a new female condom among young adults in urban Zambia. Reproductive health. 2019;16(1):1\u20138.","journal-title":"Reproductive health"},{"issue":"5","key":"3841_CR4","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10461-016-1627-z","volume":"21","author":"FM Koechlin","year":"2017","unstructured":"Koechlin FM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325\u201335.","journal-title":"AIDS Behav"},{"key":"3841_CR5","doi-asserted-by":"publisher","first-page":"e25298","DOI":"10.1002\/jia2.25298","volume":"22","author":"CL Celum","year":"2019","unstructured":"Celum CL, et al. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22:e25298.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"3841_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/0272989X17729376","volume":"38","author":"M Quaife","year":"2018","unstructured":"Quaife M, et al. Divergent preferences for HIV prevention: a discrete choice experiment for multipurpose HIV prevention products in South Africa. Med Decis Making. 2018;38(1):120\u201333.","journal-title":"Med Decis Making"},{"issue":"22","key":"3841_CR7","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","volume":"375","author":"A Nel","year":"2016","unstructured":"Nel A, et al. Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J Med. 2016;375(22):2133\u201343.","journal-title":"N Engl J Med"},{"issue":"22","key":"3841_CR8","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"key":"3841_CR9","unstructured":"Mayo AJ, et al., Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. AIDS and Behavior, 2021: p.\u00a01\u201311."},{"issue":"8","key":"3841_CR10","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","volume":"31","author":"ET Montgomery","year":"2017","unstructured":"Montgomery ET, et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS. 2017;31(8):1159.","journal-title":"AIDS"},{"issue":"11","key":"3841_CR11","doi-asserted-by":"publisher","first-page":"e25634","DOI":"10.1002\/jia2.25634","volume":"23","author":"ER Brown","year":"2020","unstructured":"Brown ER, et al. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo\u2010controlled trial. J Int AIDS Soc. 2020;23(11):e25634.","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"3841_CR12","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/S2352-3018(20)30304-0","volume":"8","author":"JM Baeten","year":"2021","unstructured":"Baeten JM, et al. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. The Lancet HIV. 2021;8(2):e87\u201395.","journal-title":"The Lancet HIV"},{"issue":"2","key":"3841_CR13","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S2352-3018(20)30300-3","volume":"8","author":"A Nel","year":"2021","unstructured":"Nel A, et al. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The Lancet HIV. 2021;8(2):e77\u201386.","journal-title":"The Lancet HIV"},{"key":"3841_CR14","unstructured":"World Health Organisation. European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings. 2021; Available from: https:\/\/www.who.int\/news\/item\/24-07-2020-european-medicines-agency-(ema)-approval-of-the-dapivirine-ring-for-hiv-prevention-for-women-in-high-hiv-burden-settings."},{"key":"3841_CR15","unstructured":"World Health Organisation. WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection. 2021; Available from: https:\/\/www.who.int\/news\/item\/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection."},{"key":"3841_CR16","unstructured":"Fokazi S. More HIV prevention options for SA women as vaginal ring is approved. 2022; Available from: https:\/\/www.timeslive.co.za\/news\/south-africa\/2022-03-16-more-hiv-prevention-options-for-sa-women-as-vaginal-ring-approved\/."},{"key":"3841_CR17","unstructured":"Gwarisa M. #BREAKING:Dapivirine, Vaginal Ring approved for use in Zimbabwe. 2021 [cited 2021 27 July]; Available from: https:\/\/healthtimes.co.zw\/2021\/07\/14\/breaking-dapivirine-vaginal-ring-approved-for-use-in-zimbabwe\/."},{"issue":"2","key":"3841_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","volume":"38","author":"E Proctor","year":"2011","unstructured":"Proctor E, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm policy mental health mental health Serv Res. 2011;38(2):65\u201376.","journal-title":"Adm policy mental health mental health Serv Res"},{"issue":"1","key":"3841_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-017-2031-8","volume":"17","author":"M Sekhon","year":"2017","unstructured":"Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):1\u201313.","journal-title":"BMC Health Serv Res"},{"issue":"11","key":"3841_CR20","doi-asserted-by":"publisher","first-page":"e0259779","DOI":"10.1371\/journal.pone.0259779","volume":"16","author":"M Sekhon","year":"2021","unstructured":"Sekhon M, van der Straten A, Team M-MS. Pregnant and breastfeeding women\u2019s prospective acceptability of two biomedical HIV prevention approaches in Sub Saharan Africa: A multisite qualitative analysis using the Theoretical Framework of Acceptability. PLoS ONE. 2021;16(11):e0259779.","journal-title":"PLoS ONE"},{"issue":"5","key":"3841_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jama.2010.1090","volume":"304","author":"K Shannon","year":"2010","unstructured":"Shannon K, Csete J. Violence, condom negotiation, and HIV\/STI risk among sex workers. JAMA. 2010;304(5):573\u20134.","journal-title":"JAMA"},{"issue":"2","key":"3841_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10461-020-03011-z","volume":"25","author":"IC Bal\u00e1n","year":"2021","unstructured":"Bal\u00e1n IC, et al. Client-centered adherence counseling with adherence measurement feedback to support use of the dapivirine ring in MTN-025 (The HOPE Study). AIDS Behav. 2021;25(2):447\u201358.","journal-title":"AIDS Behav"},{"issue":"7","key":"3841_CR23","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s10461-020-03145-0","volume":"25","author":"S O\u2019Rourke","year":"2021","unstructured":"O\u2019Rourke S, et al. The PrEP journey: Understanding how internal drivers and external circumstances impact the PrEP trajectory of adolescent girls and young women in Cape Town, South Africa. AIDS Behav. 2021;25(7):2154\u201365.","journal-title":"AIDS Behav"},{"issue":"6","key":"3841_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11904-021-00578-7","volume":"18","author":"E Rousseau","year":"2021","unstructured":"Rousseau E, et al. Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations \u2014 Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine. Curr HIV\/AIDS Rep. 2021;18(6):500\u20137.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"3841_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-pharmtox-011711-113247","volume":"52","author":"TF Blaschke","year":"2012","unstructured":"Blaschke TF, et al. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52:275\u2013301.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"3841_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40271-017-0251-y","volume":"10","author":"J Ostermann","year":"2017","unstructured":"Ostermann J, et al. Preferences for health interventions: improving uptake, adherence, and efficiency. The Patient-Patient-Centered Outcomes Research. 2017;10(4):511\u20134.","journal-title":"The Patient-Patient-Centered Outcomes Research"},{"issue":"4","key":"3841_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/jwh.2009.1576","volume":"19","author":"G Guest","year":"2010","unstructured":"Guest G, et al. Acceptability of PrEP for HIV prevention among women at high risk for HIV. J Women\u2019s Health. 2010;19(4):791\u20138.","journal-title":"J Women\u2019s Health"},{"key":"3841_CR28","unstructured":"Ngure K Choice and Adherence to Dapivirine Ring or Oral PrEP by Young African Women in REACH. 2022; Available from: https:\/\/www.natap.org\/2022\/CROI\/croi_90.htm."},{"key":"3841_CR29","doi-asserted-by":"crossref","unstructured":"Minnis AM, et al, Young women\u2019s stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa. Journal of acquired immune deficiency syndromes (1999), 2019. 80(4): p.\u00a0394.","DOI":"10.1097\/QAI.0000000000001945"},{"issue":"3","key":"3841_CR30","doi-asserted-by":"publisher","first-page":"e25094","DOI":"10.1002\/jia2.25094","volume":"21","author":"A van der Straten","year":"2018","unstructured":"van der Straten A, et al. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018;21(3):e25094.","journal-title":"J Int AIDS Soc"},{"key":"3841_CR31","doi-asserted-by":"crossref","unstructured":"Donnell D, et al. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study. The Lancet HIV; 2021.","DOI":"10.1016\/S2352-3018(21)00048-5"},{"issue":"5","key":"3841_CR32","doi-asserted-by":"publisher","first-page":"e25283","DOI":"10.1002\/jia2.25283","volume":"22","author":"ET Montgomery","year":"2019","unstructured":"Montgomery ET, et al. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019;22(5):e25283.","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"3841_CR33","doi-asserted-by":"publisher","first-page":"e1003670","DOI":"10.1371\/journal.pmed.1003670","volume":"18","author":"C Celum","year":"2021","unstructured":"Celum C, et al. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. PLoS Med. 2021;18(6):e1003670.","journal-title":"PLoS Med"},{"issue":"11","key":"3841_CR34","doi-asserted-by":"publisher","first-page":"e25636","DOI":"10.1002\/jia2.25636","volume":"23","author":"CL Celum","year":"2020","unstructured":"Celum CL, et al. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial. J Int AIDS Soc. 2020;23(11):e25636.","journal-title":"J Int AIDS Soc"},{"key":"3841_CR35","doi-asserted-by":"crossref","unstructured":"Husnik MJ, et al. Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention. AIDS and Behavior; 2021. pp.\u00a01\u201314.","DOI":"10.1007\/s10461-021-03231-x"},{"issue":"1","key":"3841_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-11335-1","volume":"21","author":"M Jackson-Gibson","year":"2021","unstructured":"Jackson-Gibson M, et al. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. BMC Public Health. 2021;21(1):1\u201313.","journal-title":"BMC Public Health"},{"key":"3841_CR37","unstructured":"Etima J, et al., Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial. AIDS and Behavior, 2021: p.\u00a01\u201310."},{"issue":"11","key":"3841_CR38","doi-asserted-by":"publisher","first-page":"e0224898","DOI":"10.1371\/journal.pone.0224898","volume":"14","author":"JB Griffin","year":"2019","unstructured":"Griffin JB, et al. Vaginal ring acceptability and related preferences among women in low-and middle-income countries: a systematic review and narrative synthesis. PLoS ONE. 2019;14(11):e0224898.","journal-title":"PLoS ONE"},{"key":"3841_CR39","doi-asserted-by":"crossref","unstructured":"Ridgeway K, et al., Vaginal ring acceptability: a systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception, 2021.","DOI":"10.1016\/j.contraception.2021.10.001"},{"key":"3841_CR40","unstructured":"Bekker L-G, et al. HPTN 067\/ADAPT Cape Town: a comparison of daily and nondaily PrEP dosing in African women. in Conference on Retroviruses and Opportunistic Infections. 2015."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-022-03841-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-022-03841-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-022-03841-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T22:27:50Z","timestamp":1677018470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-022-03841-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3841"],"URL":"https:\/\/doi.org\/10.1007\/s10461-022-03841-z","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"27 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the following Institutional Review Boards\/Ethics Committees and Drug Regulatory Authorities: Prevention Sciences Research Committee of the US National Institute of Allergy and Infectious Diseases; US Food and Drug Administration; National Health Sciences Research Committee of Malawi; Johns Hopkins University Bloomberg School of Public Health Institutional Review Board; University of North Carolina at Chapel Hill Institutional Review Board; Pharmacy, Medicines and Poisons Board of Malawi; University of Cape Town: Human Research Ethics Committee; Biomedical Research Ethics Committee University of KwaZulu-Natal; South African Medical Research Council Ethics Committee; Human Research Ethics Committee: (Medical), University of Witwatersrand, Johannesburg; Medicines Control Council of South Africa; Joint Clinical Research Centre Institutional Review Board; Uganda National Council for Science and Technology; Johns Hopkins University School of Medicine Institutional Review Board; National Drug Authority of Uganda; Medical Research Council of Zimbabwe; Committee on Human Research, University of California - San Francisco; Joint Parirenyatwa Hospital and College of Health Sciences Research Ethics; Research Council of Zimbabwe; Medicines Control Authority of Zimbabwe.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}